Background <p>Secondary rhinoseptoplasty (RSP) is technically demanding due to scarring, altered anatomy, and limited septal cartilage. Comparative data on technique selection and complications versus primary procedures are sparse.</p> Methods <p>We analyzed 2,536 consecutive RSPs (2010–2020) at a single center (2,067 primary; 469 secondary). Techniques included columellar strut grafts (CSG), tongue-in-groove (TIG), spreader grafts (SG), spreader flaps (SF), extracorporeal septal reconstruction (ESR), and ear cartilage grafting. Major complications were bleeding, infection, septal perforation, midvault collapse, tip ptosis/derotation, and bony edges. Associations were tested with chi-squared (χ²), Phi coefficients, and logistic regression.</p> Results <p>Mean age was 28.1 (primary) and 31.6 years (secondary). Technique use shifted in secondary RSP: SF decreased (35.22% to 13.01%), ESR increased (14.66% to 24.31%), and ear cartilage increased (0.92% to 8.74%); SG predominated (SG: SF 1.4:1 primary vs. 2.8:1 secondary). Secondary cases were strongly associated with greater use of ESR (OR 2.043, <i>p</i> &lt; 0.001), and ear cartilage (OR 4,37, <i>p</i> &lt; 0.001). Overall, 22/2,536 cases (0,87%) required correction for clinically significant tip derotation (6 secondary). Suspension sutures showed a weak association with tip derotation; CSG and TIG showed no association. Midvault collapse was rare (0.64% secondary vs. 0.44% primary; not significant). In secondary cases with ESR (24.31%, <i>n</i> = 114), no septal perforations or surgical bleeding occurred.</p> Conclusions <p>Secondary RSP more often requires ESR and graft-based reconstruction and favors SG over SF, yet major complication rates did not increase. CSG and TIG provided reliable tip support; suspension sutures warrant cautious use. Tailored technique selection enables safe revision RSP despite greater technical complexity.</p> Level of evidence <p>Level III, therapeutic study.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Complication rates and cornerstones in secondary rhinoseptoplasty: a large-scale registry study

  • Krasen Pirindov,
  • Michael Bromba,
  • Jan Restel,
  • Alexios Farsakis,
  • Iris Lebbe,
  • Andreas Dietz,
  • Andreas Dacho

摘要

Background

Secondary rhinoseptoplasty (RSP) is technically demanding due to scarring, altered anatomy, and limited septal cartilage. Comparative data on technique selection and complications versus primary procedures are sparse.

Methods

We analyzed 2,536 consecutive RSPs (2010–2020) at a single center (2,067 primary; 469 secondary). Techniques included columellar strut grafts (CSG), tongue-in-groove (TIG), spreader grafts (SG), spreader flaps (SF), extracorporeal septal reconstruction (ESR), and ear cartilage grafting. Major complications were bleeding, infection, septal perforation, midvault collapse, tip ptosis/derotation, and bony edges. Associations were tested with chi-squared (χ²), Phi coefficients, and logistic regression.

Results

Mean age was 28.1 (primary) and 31.6 years (secondary). Technique use shifted in secondary RSP: SF decreased (35.22% to 13.01%), ESR increased (14.66% to 24.31%), and ear cartilage increased (0.92% to 8.74%); SG predominated (SG: SF 1.4:1 primary vs. 2.8:1 secondary). Secondary cases were strongly associated with greater use of ESR (OR 2.043, p < 0.001), and ear cartilage (OR 4,37, p < 0.001). Overall, 22/2,536 cases (0,87%) required correction for clinically significant tip derotation (6 secondary). Suspension sutures showed a weak association with tip derotation; CSG and TIG showed no association. Midvault collapse was rare (0.64% secondary vs. 0.44% primary; not significant). In secondary cases with ESR (24.31%, n = 114), no septal perforations or surgical bleeding occurred.

Conclusions

Secondary RSP more often requires ESR and graft-based reconstruction and favors SG over SF, yet major complication rates did not increase. CSG and TIG provided reliable tip support; suspension sutures warrant cautious use. Tailored technique selection enables safe revision RSP despite greater technical complexity.

Level of evidence

Level III, therapeutic study.